Author:
Bontenbal M.,Planting A. S. Th.,Rodenburg C. J.,Dees A.,Verweij J.,Bartels C. C. M.,Alexieva-Figusch J.,van Putten W. L. J.,Klijn J. G. M.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Henderson IC, Harris JR, Kinne DW, Hellman S: Cancer of the breast. In: DeVita VT, Hellman S, Rosenburg SA (eds) Cancer, Principles and Practice of Oncology, Lippincott, Philadelphia, 1989, pp 1197–1268
2. Cersosimo RJ, Hong WK: Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue. J Clin Oncol 4: 425–439, 1986
3. Neidhart JA, Gochnour D, Roach R, Hoth D, Young D: A comparison of mitoxantrone and doxorubicin in breast cancer. J Clin Oncol 4: 672–677, 1986
4. Henderson IG, Allegra JC, Woodcock T, Wolff S, Bryan S, Cart-wright K, Dukart G, Henry D: Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. J Clin Oncol 7: 560–571, 1989
5. Nylen U, Baral E, Svane G, Rutqvist LE: Weekly doxorubicin in the treatment of breast cancer. Acta Oncol 28: 515–517, 1989
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献